Omar Siddiqi | Profiles RNS

Omar Siddiqi, MD

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Dept of Medicine

Cardiovascular Medicine

MD, Washington University School of Medicine
BS, University of Rhode Island

Pronouns: he/him/his

Websites

	Boston Medical Center Provider Profile
	LinkedIn

ORCID : 0000-0001-7813-1623

Omar Siddiqi, MD is an Assistant Professor of Medicine in Cardiovascular Medicine at the Chobanian and Avedisian School of Medicine, and he is the Program Director of the Cardiovascular Medicine Fellowship Program. As director of the cardiology fellowship curriculum, he is credited with developing an academic half day for cardiovascular medicine fellows, developing an echocardiography curriculum utilizing the CAE echocardiography simulator housed in the Solomont Simulation Center, and starting an Imaging Show and Tell conference. These efforts have been recognized with two Cardiovascular Medicine Fellowship Faculty Teaching Awards which he won in 2015 and 2018. At the Chobanian and Avedisian School of Medicine, he serves as co-director of the second year medical school cardiovascular pathophysiology module. His research interests in medical education include the development of simulation-based curricula and the integration of team-based learning (TBL) in teaching ECGs. His clinical interests include cardiac amyloidosis and echocardiography, and he is an attending cardiologist in the BU Amyloidosis Center. His clinical research interests are around the assessment of novel therapies for the treatment of cardiac amyloidosis. He has served as Clinical Investigator of five studies, including two currently.

Member
Boston University
Amyloidosis Center

BMC Research

A Phase 2, randomized, placebo-controlled, subject and investigator blinded, multi-center study…
06/09/2020 - 06/09/2023 (PI)
Novartis Pharma Corp

Myocardial ischemia and Transfusion (MINT)-CCC
06/01/2017 - 05/31/2022 (PI)
Rutgers, New Jersey Medical School NIH-NHLBI

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles.

Staron, Andrew
Edwards, Camille
Gopal, Deepa
Ruberg, Frederick
Sloan, J.
Berk, John
Lau, K.H. Vincent
Mendelson, Lisa
Kaku, Michelle
Siddiqi, Omar
Szalat, Raphael
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 35731907

Prokaeva T, Joshi T, Klimtchuk ES, Gibson VM, Spencer B, Siddiqi O, Nedelkov D, Hu Y, Berk JL, Cuddy SAM, Dasari S, Chiu A, Choate LA, McPhail ED, Cui H, Chen H, Burks EJ, Sanchorawala V, Connors LH. A novel substitution of proline (P32L) destabilises ß2-microglobulin inducing hereditary systemic amyloidosis. Amyloid. 2022 Dec; 29(4):255-262.View Related Profiles.

Klimtchuk, Elena
Burks, Eric
Chen, Hui
Berk, John
Connors, Lawreen
Siddiqi, Omar
Prokaeva, Tatiana
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 35575118; DOI: 10.1080/13506129.2022.2072199;

Siddiqi OK, Mints YY, Berk JL, Connors L, Doros G, Gopal DM, Kataria S, Lohrmann G, Pipilas AR, Ruberg FL. Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid. 2022 Jun; 29(2):71-78.View Related Profiles.

Gopal, Deepa
Ruberg, Frederick
Doros, Gheorghe
Berk, John
Connors, Lawreen
Siddiqi, Omar

PMID: 35083944; PMCID: PMC9258521; DOI: 10.1080/13506129.2021.2000388;

Alreshq R, Tugal D, Siddiqi O, Ruberg F. Conduction abnormalities and role of cardiac pacing in cardiac amyloidosis: A systematic review. Pacing Clin Electrophysiol. 2021 Dec; 44(12):2092-2099.View Related Profiles.

Tugal, Derin
Ruberg, Frederick
Siddiqi, Omar

PMID: 34632598

Benbrahim M, Norman K, Sanchorawala V, Siddiqi OK, Hughes D. A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis. J Cardiovasc Pharmacol. 2021 05 01; 77(5):544-548.View Related Profiles.

Siddiqi, Omar
Sanchorawala, Vaishali

PMID: 33657048

Lohrmann G, Patel MA, Brauneis D, Sanchorawala V, Sarosiek S, Vellanki N, Siddiqi OK, Ruberg FL, Gopal DM. Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation. JACC CardioOncol. 2020 Dec; 2(5):721-731.View Related Profiles.

Gopal, Deepa
Ruberg, Frederick
Siddiqi, Omar
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 33511355; PMCID: PMC7839967; DOI: 10.1016/j.jaccao.2020.10.010;

Ruberg FL, Siddiqi OK. In Search of the Holy Grail: Evidence of Amyloid Fibril Regression in ATTR Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2021 01; 14(1):200-202.View Related Profiles.

Ruberg, Frederick
Siddiqi, Omar

PMID: 33129738; PMCID: PMC8543316; DOI: 10.1016/j.jcmg.2020.08.021;

Ruberg FL, Siddiqi OK. Hepatocyte Growth Factor and Cardiac Amyloidosis. JACC CardioOncol. 2020 Mar; 2(1):67-69.View Related Profiles.

Ruberg, Frederick
Siddiqi, Omar

PMID: 32647833; PMCID: PMC7347296; DOI: 10.1016/j.jaccao.2020.02.004;

Ruberg FL and Siddiqi OK. Hepatocyte Growth Factor and Cardiac Amyloidosis. JACC: Cardio Oncology. 2020; 2(1):67-69.

Lohrmann G, Pipilas A, Mussinelli R, Gopal DM, Berk JL, Connors LH, Vellanki N, Hellawell J, Siddiqi OK, Fox J, Maurer MS, Ruberg FL. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis. J Card Fail. 2020 Sep; 26(9):753-759.View Related Profiles.

Pipilas, Alexandra
Gopal, Deepa
Ruberg, Frederick
Berk, John
Connors, Lawreen
Siddiqi, Omar

PMID: 31805416; PMCID: PMC7758872; DOI: 10.1016/j.cardfail.2019.11.024;

Showing 10 of 24 results. Show More

Gopal DM, Ruberg FL, Siddiqi OK. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Curr Heart Fail Rep. 2019 10; 16(5):180-188.View Related Profiles.

Gopal, Deepa
Ruberg, Frederick
Siddiqi, Omar

PMID: 31520266

Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309.View Related Profiles.

Sloan, J.
Quillen, Karen
Siddiqi, Omar
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 30664726

Pandey S, Siddiqi OK. Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality. J Nucl Cardiol. 2020 02; 27(1):225-227.View Related Profiles.

Siddiqi, Omar
Pandey, Shivda

PMID: 30054791

Siddiqi OK, Sanchorawala V, Ruberg FL. Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics. Circ Cardiovasc Imaging. 2018 05; 11(5):e007826.View Related Profiles.

Ruberg, Frederick
Siddiqi, Omar
Sanchorawala, Vaishali

PMID: 29752394

Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid. 2018 Jun; 25(2):139-140.View Related Profiles.

Ruberg, Frederick
Berk, John
Siddiqi, Omar
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 29516761

Siddiqi OK, Ruberg FL. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018 01; 28(1):10-21.View Related Profiles.

Ruberg, Frederick
Siddiqi, Omar

PMID: 28739313; PMCID: PMC5741539; DOI: 10.1016/j.tcm.2017.07.004;

Siddiqi OK, Ruberg FL. Challenging the myths of cardiac amyloidosis. Eur Heart J. 2017 06 21; 38(24):1909-1912.View Related Profiles.

Ruberg, Frederick
Siddiqi, Omar

PMID: 28444296; DOI: 10.1093/eurheartj/ehx210;

Siddiqi OK, Smoot KJ, Dufour AB, Cho K, Young M, Gagnon DR, Ly S, Temiyasathit S, Faxon DP, Gaziano JM, Kinlay S. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease. Heart. 2015 Oct; 101(19):1569-76.View Related Profiles.

Gagnon, David
Gaziano, J. Michael
Siddiqi, Omar
Kinlay, Scott

PMID: 26209334; PMCID: PMC4580134; DOI: 10.1136/heartjnl-2014-307168;

O'Leary JM, Siddiqi OK, de Ferranti S, Landzberg MJ, Opotowsky AR. The Changing Demographics of Congenital Heart Disease Hospitalizations in the United States, 1998 Through 2010. JAMA. 2013 Mar 13; 309(10):984-986. PMID: 23471480

Siddiqi OK, Faxon DP. Very late stent thrombosis: current concepts. Curr Opin Cardiol. 2012 Nov; 27(6):634-41. PMID: 23075822; DOI: 10.1097/HCO.0b013e3283587c7e;

Opotowsky AR, Siddiqi OK, D'Souza B, Webb GD, Fernandes SM, Landzberg MJ. Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart. 2012 Jan; 98(2):145-51. PMID: 21990383; DOI: 10.1136/heartjnl-2011-300828;

Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009 Jul 28; 54(5):460-7. PMID: 19628123; DOI: 10.1016/j.jacc.2009.04.037;

Dayani PN, Siddiqi OK, Holekamp NM. Safety of intravitreal injections in patients receiving warfarin anticoagulation. Am J Ophthalmol. 2007 Sep; 144(3):451-3. PMID: 17765427

Basha MR, Murali M, Siddiqi HK, Ghosal K, Siddiqi OK, Lashuel HA, Ge YW, Lahiri DK, Zawia NH. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB J. 2005 Dec; 19(14):2083-4. PMID: 16230335

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 24 publications over 13 distinct years, with a maximum of 4 publications in 2020